Sore Throat Drugs Heading Behind The Counter In France Over Safety Fears
France's drugs agency wants to restrict sales of OTC sore throat treatments marketed by Sanofi and others to behind the pharmacy counter due to fears of potential adverse events.
You may also be interested in...
Speaking exclusively to HBW Insight, French OTC association Afipa reflects on a difficult 2019 which saw tighter restrictions introduced on the sale of popular consumer health products. The trade group believes the industry's best prospects for a brighter future are rebuilding relations with national drug regulator ANSM and to getting self-care higher up the agenda of the French government.
Fears over patient safety will see common OTC drugs including paracetamol moved behind the counter in France from January 2020.
France's medicines agency wants to restrict sales of OTC drugs containing paracetamol, ibuprofen and aspirin to behind the pharmacy counter due to safety concerns.